创业慧康（300451）主营业务：公司主营业务已从以产品开发销售为主逐渐向系统建设、服务与运营多 领域拓展,主要包括:智慧医卫、互联网医疗、医疗物联网、医疗健康大数据、健康城市、智慧医保等整 体解决方案、系统承建及运维、运营服务等创新业务。 创业慧康2025年三季报显示，前三季度公司主营收入8.62亿元，同比下降26.26%；归母净利润-1.22亿 元，同比下降331.69%；扣非净利润-1.42亿元，同比下降382.12%；其中2025年第三季度，公司单季度 主营收入2.85亿元，同比下降35.5%；单季度归母净利润-4166.95万元，同比下降264.2%；单季度扣非净 利润-4740.49万元，同比下降288.66%；负债率20.27%，投资收益443.72万元，财务费用-531.93万元， 毛利率49.87%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，根据市场公开信息整理，11月19日创业慧康（300451）新增【阿里】概念。 新增概念原因：公司和阿里系公司、腾讯及相关公司在云计算、移动支付等智慧医疗方 ...

证券之星消息，根据天眼查APP-财产线索数据整理，根据武汉市卫生健康信息中心（武汉市人口信息 监测站）11月16日发布的《武汉市卫生健康信息中心（武汉市人口信息监测站）基卫云医保药品耗材追 溯码接口对接服务项目中标（成交）结果公告》内容显示，创业慧康科技股份有限公司中标，详情如 下： 数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 采购方：武汉市卫生健康信息中心（武汉市人口信息监测站） 供应商：创业慧康科技股份有限公司 中标金额：40.17 地区：湖北省 发布日期：2025-11-16 标题：武汉市卫生健康信息中心（武汉市人口信息监测站）基卫云医保药品耗材追溯码接口对接服务项 目中标（成交）结果公告 通过天眼查大数据分析，创业慧康科技股份有限公司共对外投资了58家企业，参与招投标项目7956次； 财产线索方面有商标信息65条，专利信息121条，著作权信息761条；此外企业还拥有行政许可74个。 ...

11月17日晚间，创业慧康（300451.SZ）披露股东权益变动，杭州更好智投管理咨询合伙企业（有限合 伙）（以下简称"杭州更好"）将通过股份受让、表决权委托、提名董事等方式，成为创业慧康的控股股 东，创业慧康仍处于无实控人状态。 长江商报消息 ●长江商报记者 徐佳 长江商报记者注意到，杭州更好的背后是港股上市公司华检医疗（01931.HK）。而耗资5亿元拿下创业 慧康控股权，华检医疗意在借助创业慧康近30年的行业积淀与前瞻性的AI布局，落地AI医疗战略。 港股上市公司并购A股公司再添重磅案例。 另一方面，华检医疗的收购也面临多重风险。继2024年业绩转亏之后，2025年前三季度，创业慧康实现 营业收入8.62亿元，同比下降26.26%；归属于上市公司股东的净利润（以下简称"归母净利润"）亏损 1.22亿元，同比下降331.69%。近两年，创业慧康归母净利润累计亏损2.96亿元。 创业慧康本次易主将分三步进行。 第一步，创业慧康原第一大股东葛航将其所持上市公司9652.51万股股份转让给杭州更好，占上市公司 总股本的6.23%。本次交易中，创业慧康每股作价5.18元，交易总金额为5亿元。 第二步，杭州更好分别 ...

Group 1 - The core point of the news is the change of control at Chuangye Huikang, with Hangzhou Genghao becoming the largest shareholder due to the debt crisis faced by founder Ge Hang [2][4] - The transaction involves Ge Hang transferring 6.23% of shares to Hangzhou Genghao for 500 million yuan, along with the delegation of voting rights for an additional 10.06% of shares [3] - Following this transaction, Hangzhou Genghao will hold a total of 12.64% of the voting rights, allowing it to nominate a majority of the board members and effectively control Chuangye Huikang [3] Group 2 - Ge Hang's debt crisis has escalated, leading to a series of share transfers and judicial freezes, resulting in a "no owner" phase for Chuangye Huikang [4][5] - The company has faced declining performance, with a projected first loss since its listing in 2024, and its market value has decreased from a peak of 25.2 billion yuan to 8.5 billion yuan [5] - The medical information industry is undergoing significant changes, with many companies facing operational challenges, including Chuangye Huikang, which is experiencing a control change amid a broader industry downturn [6] Group 3 - The acquisition by Hangzhou Genghao is seen as a strategic move to leverage AI capabilities in the medical field, as Chuangye Huikang has a substantial data foundation for AI model training [8] - Despite previous diversification attempts, over 90% of Chuangye Huikang's revenue still comes from the medical sector, indicating limited success in expanding beyond its core business [7][8]

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300730 | 科创信息 | 14.41 | -19.99% | 13.50万 | | 1.95亿 | | 688168 | 安博通 | 90.59 | -4.98% | 3.47万 | | 3.17亿 | | 002253 | *ST智胜 | 9.79 | -3.55% | 9.55万 | 9380.70万 | | | 301162 | 国能日新 | 57.69 | -3.11% | 1.47万 | 8554.50万 | | | 300379 | *ST东通 | 2.01 | -2.90% | 47.23万 | 9555.45万 | | | 688435 | 英方软件 | 51.40 | -2.50% | 5.93万 | | 3.02亿 | | 300605 | 恒経信息 | 17.04 | -2.35% | 15.55万 | | 2.64亿 | | 002298 | 中电鑫龙 | 13.12 | -2.31% | 176.89 ...

Market Overview - The Shanghai Composite Index closed at 3939.81 points, with a decline of 0.81%, and the total trading volume of A-shares reached 1,945.96 billion yuan [1] Stocks Breaking the Annual Line - A total of 35 A-shares have surpassed the annual line, with notable stocks showing significant deviation rates including: - Guangyun Technology with a deviation rate of 19.13% - Longxun Co., Ltd. at 15.24% - Central Plaza at 7.88% [1] Top Performers - The top three stocks with the highest deviation rates are: 1. Guangyun Technology: Today's price increase of 19.99%, turnover rate of 9.16%, annual line price of 13.81 yuan, latest price at 16.45 yuan [1] 2. Longxun Co., Ltd.: Price increase of 20.00%, turnover rate of 19.74%, annual line price of 69.30 yuan, latest price at 79.86 yuan [1] 3. Central Plaza: Price increase of 10.11%, turnover rate of 9.48%, annual line price of 3.63 yuan, latest price at 3.92 yuan [1] Additional Notable Stocks - Other stocks that have recently crossed the annual line with lower deviation rates include: - Tianlong Group, Jinyu Medical, and Meili Cloud, which have just crossed the annual line [1]

Core Points - The Shanghai Composite Index closed at 3939.81 points, above the six-month moving average, with a decline of 0.81% [1] - The total trading volume of A-shares reached 1,945.96 billion yuan [1] - A total of 51 A-shares have surpassed the six-month moving average, with notable stocks showing significant deviation rates [1] Summary by Category Market Performance - The Shanghai Composite Index is currently at 3939.81 points, indicating a slight decline of 0.81% [1] - The total trading volume for A-shares today was 1,945.96 billion yuan [1] Stocks Surpassing Six-Month Moving Average - 51 A-shares have broken through the six-month moving average, with the highest deviation rates observed in: - Longxun Co., Ltd. with a deviation rate of 18.63% and a price increase of 20.00% [1] - Meideng Technology with a deviation rate of 14.56% and a price increase of 22.82% [1] - Jingchen Co., Ltd. with a deviation rate of 9.04% and a price increase of 11.90% [1] Additional Notable Stocks - Other stocks with significant performance include: - Guangyun Technology with a deviation rate of 8.67% and a price increase of 19.99% [1] - Qixin Group with a deviation rate of 8.30% and a price increase of 10.07% [1] - Haohan Deep Technology with a deviation rate of 6.70% and a price increase of 9.03% [1]

Core Points - The Shanghai Composite Index is at 3937.29 points, with a decrease of 0.87%, and the total trading volume of A-shares is 1,593.98 billion yuan [1] - 30 A-shares have surpassed their annual line today, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - Notable stocks that have broken through the annual line include: - Guangyun Technology (光云科技) with a deviation rate of 19.13% and a price increase of 19.99% [1] - Longxun Co., Ltd. (龙迅股份) with a deviation rate of 15.24% and a price increase of 20.00% [1] - Haohan Depth (浩瀚深度) with a deviation rate of 6.26% and a price increase of 8.69% [1] Trading Metrics - The trading volume for A-shares today is reported at 1,593.98 billion yuan [1] - The turnover rates for the top stocks that broke through the annual line vary, with Longxun Co., Ltd. at 17.65% and Guangyun Technology at 8.82% [1] Deviation Rates - Stocks with smaller deviation rates that have just crossed the annual line include: - Tianlong Group (天龙集团) with a deviation rate of 0.00% [2] - Jinyu Medical (金域医学) with a deviation rate of 0.05% [2] - Lihua Micro (力合微) with a deviation rate of 0.07% [2]

A股三大指数盘整，软件开发板块表现相对强势，创业板软件ETF华夏（159256）盘中涨超 0.70%，其持仓股创业惠康涨超6%，卫宁健康涨超2%，万兴科技涨1.81%，指南针涨1.78%，昆仑万维 涨1.47%。 （责任编辑：董萍萍 ） 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 华泰证券指出，6G发展将沿"基础设施—组件—应用"的产业链条分阶段释放投资机遇。参照5G产 业化经验，6G的推进将率先利好网络规划、通信基础设施施工与设备制造相关企业；随着技术标准逐 步明确，天线、PCB、滤波器、光模块等核心元器件领域有望迎来需求增长；最终在规模商用阶段，消 费端应用市场或将迎来爆发。该机构特别强调，通感一体、星地融合等前沿技术不仅为软件与算法企业 带来增量需求，也为国产供应链企业提供了切入全球市场的机遇。 相关产品：创业板软件ETF华夏（159256）、创业板200ETF华夏（159573）、人工智能AI ...

Group 1: Company Announcements - Yaxing Chemical plans to acquire 100% equity of Tianyi Chemical through a combination of share issuance and cash payment, with the transaction expected to add bromine series fine chemical products to its portfolio [1] - Jierong Technology elected Zhao Xiaoqun as the new chairman following the resignation of Zhang Shouzhi due to work adjustments [2] - Huan Tai Liquor's controlling shareholder plans to increase its stake in the company by investing between 70 million to 140 million yuan within six months [5] - Unigroup plans to acquire 1.28 million USD worth of shares in H3C, increasing its ownership from 81% to 82.8% [7] - Daily Interactive intends to invest up to 10 million yuan in the Yuhang AI Fund, which has a total scale of up to 100 million yuan [11] - Daan Gene's indirect controlling shareholder is set to change to Guangzhou Pharmaceutical Group, which will control 26.63% of the company after the completion of share transfers [12] Group 2: Industry Insights - The basic chemical industry is represented by Yaxing Chemical, which focuses on chlorinated polyethylene and caustic soda production [1] - Jierong Technology operates in the electronic industry, specializing in precision molds and components [2] - Huan Tai Liquor is part of the food and beverage industry, specifically in the production and sale of alcoholic beverages [5] - Unigroup is involved in the IT services sector, providing comprehensive ICT infrastructure and services [7] - Daily Interactive operates in the software development industry, offering data intelligence products and solutions [11] - Daan Gene is in the medical biotechnology sector, focusing on molecular diagnostic technologies [12]